GeneGuide Company
GeneGuide is a Swiss company that uses their Genome-Based Drug Discovery technology along with human behavioral, genetic, and neuroimaging data to identify new drug targets and compounds for treating neuropsychiatric disorders. They conduct PoC clinical trials on promising drug candidates.
Estimated Revenue:
$61.4 million
Industry:
Gene Therapy
Founded Date:
2013
Headquarters:
Basel